The buyback record date is 30th May 2024 and a total of 10,28,881 shares will be included in the tender offer, which is 0.82% of the outstanding equity shares.
Record date
Ajanta Pharma has been performing well and generated a cash flow of Rs. 812 cr. Its cash conversion ratio is 69%. With this, the Board of Directors decided to announce the buyback of shares.
The reason behind buyback
The company’s shares were trading in a range of Rs. 2364.00 to Rs. 2540 on Friday. It also reached a 52-week high at Rs. 2540.